Dr. Alan J. Kivitz, MD

Dr. Kivitz practices at UPMC Altoona in Altoona, Pennsylvania, part of University of Pittsburgh Medical Center.

Dr. Kivitz's NPI, 1447259023, was assigned on July 18, 2005. Dr. Kivitz graduated from Albany Medical College of Union University in 1982. Dr. Kivitz holds Pennsylvania license MD026744E.

Dr. Kivitz's primary practice is UPMC Altoona, at 620 Howard Avenue, Altoona, PA 16601 in Blair County. The practice phone is (814) 889-2011.

Dr. Kivitz's primary practice is UPMC Altoona in Altoona, Pennsylvania, part of University of Pittsburgh Medical Center. Dr. Kivitz is also affiliated with Penn Highlands DuBois. The medical group on file is Phoenix Physical Therapy. Dmand AI also links Dr. Kivitz to 3 more hospitals, 4 group practices and clinics, 4 medical groups and 1 therapy and rehab clinic, each named with a free account.

Dmand AI tracks the electronic health record (EHR) system at each site where Dr. Kivitz practices, 10 sites in all. Vendor and product names are available with a free account.

Rheumatology is Dr. Kivitz's primary specialty in the NPI Registry, under taxonomy code 207RR0500X. Dr. Kivitz is licensed in Pennsylvania.

CMS data shows 228,477 Medicare services from Dr. Kivitz across 90 procedure codes in 2024, for 1,014 Medicare patients. Medicare paid $2,045,455 for them. Every service was in an office.

CMS counts 1,014 Medicare patients who saw Dr. Kivitz in 2024. The largest group is 65 to 74, with 561 patients. 75% of them have arthritis, and 75% have high blood pressure. 7% are also on Medicaid. Their average risk score is 1.20, where 1.00 is the Medicare average.

Across all payers, Dmand AI patient panel data puts Dr. Kivitz's median patient age at 69, with 69% women.

In 2024, Dr. Kivitz wrote 4,157 Medicare Part D claims for 1,128 patients. 86% of them were for generic drugs. CMS names the drug for 3,906 of them, across 38 drugs with 11 or more claims each, at $2,660,420 in total drug cost. In 2023, CMS named 4,007 claims across 41 drugs.

CMS publishes a Merit-based Incentive Payment System (MIPS) score of 83 out of 100 for Dr. Kivitz for performance year 2024, reported as part of a group. Dr. Kivitz accepts Medicare assignment, so Medicare's approved amount is taken as full payment.

Dmand AI links 146 papers to Dr. Kivitz, published from 2011 to 2024. 2019 was the busiest year, with 15. The most frequent topics are Double-Blind Method, Antirheumatic Agents and Arthritis, Rheumatoid. Dr. Kivitz has published most often in Rheumatol Ther. Dr. Kivitz's most frequent co-authors are Mark Christopher Genovese, MD, Beatrix Bartok, MD and Philip J. Mease, MD.

Dmand AI links Dr. Kivitz to 36 clinical trials, 3 of them phase 3 studies. 3 are still active or recruiting. Conditions studied include Rheumatic Diseases, Arthritis, Rheumatoid and Osteoarthritis. Eli Lilly and Company sponsors the most, 13. Open Payments lists research payments to Dr. Kivitz that name 29 trials.

CMS Open Payments shows 4,993 general payments to Dr. Kivitz from 66 drug and device companies from 2016 to 2025. Speaker and faculty fees make up the largest share, 46% of the total. Abbvie Inc. paid the most, $232,640. It also lists 246 research payments totaling $270,611 from 2016 to 2025, naming 29 clinical trials.

Dr. Kivitz graduated from Albany Medical College of Union University in 1982.